Upbeat Apple earnings and strong jobs data lifted the markets to a higher open with the Dow gaining 50 points to 19,914. Nasdaq climed 23 points to 5,638.
On the upside
Oneok (NYSE: OKE) will buy the remaining shares of Oneok Partners (NYSE: OKS) that it does not already own for approximately $9.3 billion in stock.
Helios and Matheson Analytics (Nasdaq: HMNY) completed beta testing the artificial intelligence technology of its subsidiary Zone Technologies.
Olin (NYSE: OLN) reversed year ago losses to post a profit for the fourth quarter.
On the downside
Catabasis Pharmaceuticals (Nasdaq: CATB) reported disappointing results from Part B of the MoveDMD trial of edasalonexent to treat Duchenne muscular dystrophy.
Synergy Pharmaceuticals (Nasdaq: SGYP) priced its public offering of more than 20 million shares of common stock at the discounted price of $6.15 per share.
Pitney Bowes (NYSE: PBI) fell to a loss for the fourth quarter.
In the broad market, advancing issues outpaced decliners by a margin of more than 2 to 1 on both the NYSE and on Nasdaq. The broader S&P 500 index rose 3 points to 2,282. Bitcoin gained $3 to $962.
